Generic Competition Intensifies as Nicergoline Breaks Monopoly Structure: The Rise of Samion Tablet
First national preparation for nicergoline Breaking of the “Samion Tablet” monopoly structure… Generic competition intensifies Samion Tablet / Ildong Pharmaceutical As the second trial of the lawsuit to cancel selective coverage for the brain function enhancer “choline alposcerate” is expected to be heard next month, “nicergoline”, which has had a restricted position in the pharmaceutical […]
Huons Global Achieves Record Performance in 2023, Stock Price Rises Over 10%
Huons Group’s new headquarters in Pangyo (Photo = Huons Global) [바이오타임즈] The stock price of Huons Global (084110) showed strength, rising more than 10%. Huons Global closed at 26,100 won on the KOSDAQ market on the 14th, up 10.36% (2,460 won) from the previous trading day. On this day, Huons Global announced that it has […]
Supply Issues Persist for Sitagliptin (Januvia) as Generic Release Approaches
Supply Issues for Diabetes Medication ‘Sitagliptin’ Raises Concerns for Pharmaceutical Companies Several pharmaceutical companies are facing challenges in meeting the demand for generic DPP-4 inhibitors used in the treatment of diabetes, specifically ‘Sitagliptin’ (brand name: Januvia). One of the main obstacles lies in the limited production capacity of the contracted consignment companies, making it difficult […]
Food and Drug Safety Administration, Forxiga generic ‘Sim Shin’ ad “No”
The Ministry of Food and Drug Safety “Using advertisements other than approved signs is contrary to the Pharmaceutical Affairs Act” response AstraZeneca “Encouraging prescriptions for indications other than approval, even off-label” A generic pharmaceutical company said “clearly the ingredients are effective and effective, there is no problem” Forxiga generic drug brochure. The efficacy and effectiveness […]
